Quick Takeaways
- Elisabeth Bjork has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $551,175.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Elisabeth Bjork
- Location
- New York, NY
- Summary
- The estimated net worth of Elisabeth Bjork is at least $551,175 dollars as of 18 Mar 2026. Elisabeth Bjork is the Director of Pharvaris N.V. and owns shares of Pharvaris N.V. (PHVS) stock worth about $379.2K. Elisabeth Bjork is the Director of ROCKET PHARMACEUTICALS, INC. and owns shares of ROCKET PHARMACEUTICALS, INC. (RCKT) stock worth about $172K.
- Signature
- /s/ Marnus Nel, Attorney-in-Fact for Elisabeth Bjork
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Elisabeth Bjork and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Pharvaris N.V. ($379,175).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Elisabeth Bjork
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PHVS | Pharvaris N.V. | Director | $379,175 | 18 Mar 2026 | ||
| RCKT, RCKTW | ROCKET PHARMACEUTICALS, INC. | Director | $172,000 | +$68,500 | +66% | 02 Jan 2026 |
Insider Transactions Reported by Elisabeth Bjork:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.